Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
5.58
-0.13 (-2.28%)
At close: Jul 10, 2026, 4:00 PM EDT
5.43
-0.15 (-2.69%)
Pre-market: Jul 13, 2026, 7:07 AM EDT
Aclaris Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Initiates $13 | Buy | Initiates | $13 | +132.97% | Jun 1, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 | Buy | Maintains | $11 | +97.13% | May 11, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $12 | Buy | Reiterates | $12 | +115.05% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $16 | Buy | Reiterates | $16 | +186.74% | May 11, 2026 |
| Wedbush | Wedbush | Buy Maintains $10 | Buy | Maintains | $10 | +79.21% | May 8, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $10 | Buy | Reiterates | $10 | +79.21% | May 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $4 | Hold | Maintains | $4 | -28.32% | May 8, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $10 | Buy | Maintains | $10 | +79.21% | May 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.